Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05993533

Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy — QuantiXa  

Venous Thromboembolic Disease Clinical Trial

Official title:
Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy

Clinical Trial Summary

The Quantra(r) hemostasis analyzer (Stago) is a recent addition to the family of global hemostasis tests. It uses ultrasound-based technology to characterize the viscoelastic properties of a whole blood sample during coagulation. The Qplus(r) cartridge consists of independent channels, each containing different reagents that provide parallel measurements of 6 parameters. This global test takes into account cellular elements such as platelets and red blood cells in clot formation, and also explores fibrinolysis. In addition, this test is of particular interest in delocalized biology, i.e. at the patient's bedside, and avoids the time-consuming laboratory centrifugation stage required for routine analyzers. In practice, this test has been developed to monitor haemostasis in patients who may present with a range of coagulopathies of various etiologies, but also in the management of haemorrhagic patients, in order to adapt the administration of blood products in particular. The Quantra (r) analyzer could therefore be of interest since it could be deployed in overseas operations to manage war casualties. Recent studies (EACTAIC-ICCVA congress, October 2021) have shown that there is a good correlation between anti-Xa activity and the CTR (coagulation time ratio) parameter of the Quantra cartridge Qplus (TM), suggesting that this automated system could be used to manage anticoagulant therapy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05993533
Study type Observational
Source Direction Centrale du Service de Santé des Armées
Contact Aurore BOUSQUET
Phone 1 43 98 52 18
Email aurore.bousquet@intradef.gouv.fr
Status Recruiting
Phase
Start date June 22, 2023
Completion date December 31, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT04414332 - Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry
Recruiting NCT03206372 - Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure
Recruiting NCT03937583 - Screening for Cancer in Patients With Unprovoked VTE Phase 4
Not yet recruiting NCT02188056 - Observational Prospectif Monocentric Registry of Patients Suffering From VIE N/A
Completed NCT04846725 - Predictors of Attempted Inferior Vena Cava Filters Retrieval.
Completed NCT01729559 - Venous Thromboembolic Prophylaxis After Major Trauma: A Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin Phase 4
Completed NCT01466426 - The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study) N/A
Recruiting NCT05150314 - Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin
Active, not recruiting NCT05396157 - Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
Active, not recruiting NCT00691470 - Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation Phase 2/Phase 3
Completed NCT04824118 - Clotting Parameters After Medical Abortion
Recruiting NCT03887806 - Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study
Not yet recruiting NCT06232551 - Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism N/A
Not yet recruiting NCT05515549 - Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients
Recruiting NCT04211181 - CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism N/A
Completed NCT04818151 - Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data
Recruiting NCT05089227 - Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study Phase 2
Completed NCT03894878 - Association Between Genetic Variant Scores and Warfarin Effect
Completed NCT00556426 - Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. N/A
Not yet recruiting NCT04158973 - CHIPs-VTE Study in Hospitalized Patients With Lung Cancer N/A